Aveeno has signed three-year collaboration with Mayo Clinic that will focus on research, education and innovation. The research programs will include preclinical and clinical investigations to advance scientific research on the power of Aveeno’s “Triple Oat” for compromised skin, according to parent company Kenvue. Through research efforts that bring together dermatological research expertise and consumer skin health insights, Kenvue said the collaboration aims to advance skin wel...